Potentially clinically relevant prostate cancer is found more frequently after complete than after partial histopathological processing of radical cystoprostatectomy specimens

Virchows Archiv

Volumn 461, Issue 6, 2012, Pages 655-661

  Fritsche, H M ^a   Aziz, A ^a   Eder, F ^a   Otto, W ^a   Denzinger, S ^a   Wieland, W F ^a   May, M ^b   Hofstadter F ^a   Hartmann, A ^c   Burger, M ^d  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b Urologische Klinik   (Germany)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^d UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Cystectomy; Cystoprostatectomy; Incidental; Prostate cancer; Urothelial carcinoma

Indexed keywords

AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CYSTECTOMY; DIAGNOSTIC ACCURACY; DISTANT METASTASIS; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER;

AGED; CYSTECTOMY; HISTOLOGICAL TECHNIQUES; HUMANS; INCIDENTAL FINDINGS; MALE; MIDDLE AGED; PROSTATE; PROSTATECTOMY; PROSTATIC NEOPLASMS; SPECIMEN HANDLING; URINARY BLADDER NEOPLASMS;

EID: 84871523836     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-012-1328-6     Document Type: Article

References (33)

1. Stenzl A, Cowan NC, De Santis M, Kuczyk MA, Merseburger AS, Ribal MJ, Sherif A, Witjes JA, European Association of Urology (2011) The updated EAU guidelines on muscle-invasive and meta-static bladder cancer. Eur Urol 59:1009-1018
2. Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, Böhle A, Palou-Redorta J, Roupret M, European Association of Urology (2011) EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder. Eur Urol 59:997-1008
3. Nagele U, Anastasiadis AG, Stenzl A, Kuczyk M (2011) Radical cystectomy with orthotopic neobladder for invasive bladder cancer: a critical analysis of long-term oncological, functional, and quality of life results. World J Urol. doi:10.1007/s0034501106494
4. Gakis G, Schilling D, Bedke J et al (2010) Incidental prostate cancer at radical cystoprostatectomy: implications for apex-sparing surgery. BJU Int 105:468-471
5. Damiano R, Di Lorenzo G, Cantiello F et al (2007) Clinicopatho-logical features of prostate adenocarcinoma incidentally discovered at time of radical cystectomy: an evidence based analysis. Eur Urol 52:648-657
6. Kouriefs C, Fazili T, Masood S, Naseem MS, Mufti GR (2005) Incidentally detected prostate cancer in cystoprostatectomy specimens. Urol Int 275:213-216
7. Revelo MP, Cookson MS, Chang SS, Shook MF, Smith JA Jr, Shappell SB (2004) Incidence and location of prostate and urothe-lial carcinoma in prostates from cystoprostatectomies: implications for possible apical sparing surgery. J Urol 171:646-651
8. Ruffion A, Manel A, Massoud Wet al (2005) Preservation of prostate during radical cystectomy: evaluation of prevalence of prostate cancer associated with bladder cancer. Urology 65:703-707
9. Pettus JA, Al-Ahmadie H, Barocas DA, Koppie TM, Herr H, Donat SM, Dalbagni G, Reuter VE, Olgac S, Bochner BH (2008) Risk assessment of prostatic pathology in patients undergoing radical cystoprostatectomy. Eur Urol 53:370-375
10. Mazzucchelli R, Barbisan F, Scarpelli M, Lopez-Beltran A, van der Kwast TH, Cheng L, Montironi R (2009) Is incidentally detected prostate cancer in patients undergoing radical cystopros-tatectomy clinically significant? Am J Clin Pathol 131:279-283
11. Heidenreich A, Bellmunt J, Bolla M, European Association of Urology et al (2011) EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur Urol 59:61-71
12. van der Kwast TH, Amin MB, Billis A, Prostate Cancer Group ISUP et al (2011) International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 2: T2 substaging and prostate cancer volume. Mod Pathol 24:16-25
13. Sehdev AE, Pan CC, Epstein JI (2011) Comparative analysis of sampling methods for grossing radical prostatectomy specimens performed for nonpalpable (stage T1c) prostatic adenocarcinoma. Hum Pathol 32:494-499
14. May M, Siegsmund M, Hammermann F, Loy V, Gunia S (2007) Visual estimation of the tumour volume in prostate cancer: a useful means for predicting biochemical-free survival after radical prostatectomy? Prostate Cancer Prostatic Dis 10:66-71
15. Epstein JI, Walsh PC, Carmichael M, Brendler CB (1994) Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA 271:368-374
16. Lee SH, Chang PL, Chen SM, Sun GH, Chen CL, Shen BY, Wu YS, Tsui KH (2006) Synchronous primary carcinomas of the bladder and prostate. Asian J Androl 8:357-359
17. Moutzouris G, Barbatis C, Plastiras D, Mertziotis N, Katsifotis C, Presvelos V, Theodorou C (1999) Incidence and histological findings of unsuspected prostatic adenocarcinoma in radical cystopros-tatectomy for transitional cell carcinoma of the bladder. Scand J Urol Nephrol 33:27-30
18. Abdelhady M, Abusamra A, Pautler SE, Chin JL, Izawa JI (2007) Clinically significant prostate cancer found incidentally in radical cystoprostatectomy specimens. BJU Int 99:326-329
19. Winfield HN, Reddy PK, Lange PH (1987) Coexisting adenocar-cinoma of prostate in patients undergoing cystoprostatectomy for bladder cancer. Urology 30:100-101
20. Pritchett TR, Moreno J, Warner NE et al (1988) Unsuspected prostatic adenocarcinoma in patients who have undergone radical cystoprostatectomy for transitional cell carcinoma of the bladder. J Urol 139:1214-1216
21. Montie JE, Wood DP Jr, Pontes JE, Boyett JM, Levin HS (1989) Adenocarcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer. Cancer 63:381-385
22. Kabalin JN, McNeal JE, Price HM, Freiha FS, Stamey TA (1989) Unsuspected adenocarcinoma of the prostate in patients undergoing cystoprostatectomy for other causes: incidence, histology and morphometric observations. J Urol 141:1091-1094
23. Abbas F, Hochberg D, Civantos F, Soloway M (1996) Incidental prostatic adenocarcinoma in patients undergoing radical cystopros-tatectomy for bladder cancer. Eur Urol 30:322-326
24. Aydin O, Cosar EF, Varinli S, Bugdatci R, Tansung Z (1999) Prostatic intraepithelial neoplasia in prostate specimens: frequency, significance and relationship to the sampling of the specimen (a retrospective study of 121 cases). Int Urol Nephrol 31:687-697
25. Yang CR, Ou YC, Ho HC et al (1999) Unsuspected prostate carcinoma and prostatic intraepithelial neoplasm in Taiwanese patients undergoing cystoprostatectomy. Mol Urol 3:33-39
26. Conrad S, Hautmann SH, Henke RP et al (2001) Detection and characterization of early prostate cancer by six systematic biopsies and fine needle aspiration cytology in prostates from bladder cancer patients. Eur Urol 39:25-29
27. Prange W, Erbersdobler A, Hammerer P et al (2001) High-grade prostatic intraepithelial neoplasia in cystoprostatectomy specimens. Eur Urol 39:30-31
28. Ward JF, Bartsch G, Sebo TJ, Pinggera GM, Blute ML, Zincke H (2004) Pathologic characterization of prostate cancers with a very low serum prostate specific antigen (0-2 ng/mL) incidental to cystoprostatectomy: is PSA a useful indicator of clinical significance? Urol Oncol 22:40-47
29. Delongchamps NB, Mao K, Theng H, Zerbib M, Debre B, Peyromaure M (2005) Outcome of patients with fortuitous prostate cancer after radical cystoprostatectomy for bladder cancer. Eur Urol 48:946-950
30. Rocco B, de Cobelli O, Leon ME et al (2006) Sensitivity and detection rate of a 12-core transperineal prostate biopsy: preliminary report. Eur Urol 49:827-833
31. Winkler MH, Livni N, Mannion EM, Hrouda D, Christmas T (2007) Characteristics of incidental prostatic adenocarcinoma in contemporary radical cystoprostatectomy specimens. BJU Int 99:554-558
32. Hosseini SY, Danesh AK, Parvin M et al (2007) Incidental pros-tatic adenocarcinoma in patients with PSA less than 4 ng/mL undergoing radical cystoprostatectomy for bladder cancer in Iranian men. Int Braz J Urol 33:167-173
33. Weizer AZ, Shah RB, Lee CT et al (2007) Evaluation of the prostate peripheral zone/capsule in patients undergoing radical cystoprostatectomy: defining risk with prostate capsule sparing cystectomy. Urol Oncol 25:460-464